A pilot experimental study on growth inhibition of human bladder cancer transplanted tumor in nude mice treated with chrysin

Qing Li,Yadi He,Zihuan Luo,Xiaobo Chen,Xin Gao,Liaoyuan Li

DOI: https://doi.org/10.3877/cma.j.issn.1674-3253.2017.04.014

2017-01-01

Abstract:Objective To investigate the inhibition effect of chrysin (ChR) on the growth of xenotransplanted tumor with human bladder cancer cell line in vivo.Methods Xenotransplanted model of a human bladder cancer cell T24 in the dorsal skin of nude mice was established.Four weeks later,40 mice were randomly divided into 5 groups.Control group (n=8):0.9％ NS injected intraperitoneally on alternate days;MMC group (n=8):MMC was injected intraperitoneally at dose of 4 mg/kg on alternate days;L-ChR group (n=8):ChR was injected intraperitoneally at dose of 20 mg/kg on alternate days;M-ChR group (n=8):ChR was injected intraperitoneally at dose of 40 mg/kg on alternate days;H-ChR group (n=8):ChR was injected intraperitoneally at dose of 80 mg/kg on alternate days.Twenty days after treatment,tumor weight,size and tumor growth inhibition rate were evaluated respectively.Results After treatment with ChR in nude mice model,the tumor growth inhibition rate of ChR in 20 mg/kg,40 mg/kg,80 mg/kg concentration was 40.5％,62.8％ and 73.4％ respectively,which was significantly different compared with control group treated with NS (P＜0.05).The changes of WBC,serum ALT,AST,BUN and creatine levels in nude mice of each ChR group were not significantly different compared with control group treated with (P＞0.05).Conclusion ChR can inhibit the tumor growth of human bladder cancer line T24 cells in nude mice and show a dose-and time-dependence.It may be a new candidate for the treatment of bladder cancer with low toxicity.